ZTS

Zoetis Inc

ZTS·98978V103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

ZTS (Zoetis Inc) is held by 345 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($2.8B), VANGUARD CAPITAL MANAGEMENT LLC ($1.9B), VANGUARD PORTFOLIO MANAGEMENT LLC ($1.7B). Net institutional sentiment: Mixed. In Q2 2026, 8 members of Congress and 161 funds bought ZTS.

345
Holders
(27 Elite)
$25.2B
Total Value
45% (356)
Consensus
161 buying - 195 selling
13F: Insider & Congress: Updated regularly
ZTS

Smart Money Verdict

View all
Loading verdict
Held by 345 funds
27 elite

Who's Trading

Source dates: Price Oct 15, 2026 · Insiders Oct 2, 2026 · Activists Jul 30, 2026 · Congress Oct 12, 2026

InsiderFJFULLER JULIEExercise 799 shSep 30, 2026
InsiderFJFULLER JULIETax 274 shSep 30, 2026
CongressGilbert CisnerosGilbert CisnerosBuy $1,001 - $15,000Sep 18, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
39.4M(+10.8%)$2.8B0.0%-49.43%
35
Decreased
26M(-0.2%)$1.9B0.0%-35.59%
0
Decreased
23.9M(-0.5%)$1.7B0.1%-35.59%
0
Increased
19.7M(+1.8%)$1.4B0.0%-38.99%
32
Unchanged
15.9M$1.1B0.8%-5.36%
0
Increased
13.3M(+17.1%)$951.8M0.1%-31.54%
37
Decreased
9.4M(-7.2%)$677.2M0.1%-49.86%
0
Decreased
8.9M(-37.2%)$638M0.0%-53.82%
0
Increased
6.6M(+12.4%)$471.7M0.4%-40.83%
42
Increased
5.9M(+5.8%)$420.5M0.1%-46.73%
40
Decreased
5.5M(-0.1%)$398.3M0.0%-35.80%
0
Increased
5.5M(+56.0%)$396.9M0.0%-41.00%
44
Decreased
5.4M(-1.9%)$386.7M0.3%-38.51%
0
New
4.2M$302.6M1.4%+5.50%
71
Increased
4M(+7.7%)$287.7M0.0%-33.59%
33
Increased
4M(+26.0%)$286.6M0.1%-43.96%
38
Decreased
3.9M(-10.8%)$282M0.1%-46.27%
0
Decreased
3.9M(-18.8%)$282M0.0%-48.48%
0
Increased
3.6M(+30.1%)$261.8M0.0%-45.98%
39
Decreased
3.6M(-2.3%)$256.4M0.1%-34.67%
0

Showing 1-20 of 363

1 / 19
ZTSZTSZoetis Inc

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used